Joincare Pharmaceutical Group Industry Co., Ltd
Clinical trials sponsored by Joincare Pharmaceutical Group Industry Co., Ltd, explained in plain language.
-
New hope for COPD patients: experimental pill aims to reduce dangerous lung Flare-Ups
Disease control Recruiting nowThis study is testing whether a new tablet called JKN2403 can help adults with moderate-to-severe COPD by reducing the frequency of serious symptom flare-ups and improving quality of life. About 120 participants will take either the real drug or a placebo pill daily for 24 weeks …
Phase: PHASE2 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New Kids' flu drug enters final testing phase
Disease control Recruiting nowThis study is testing a new oral medicine called JKN2301 to treat the flu in children aged 2 to 11 years. It will compare the new medicine's safety and how well it works against an existing flu treatment. Researchers will measure how quickly children feel better and how long the …
Phase: PHASE3 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
First human tests begin for new antibiotic candidate
Knowledge-focused Recruiting nowThis is a very early, first-in-human study to check the safety and how the body processes a new antibiotic drug called JKN2501. It will involve 66 healthy Chinese adults who will receive either the drug or a placebo. The main goal is to see if the drug is safe and to measure its …
Phase: PHASE1 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC